Navigation Links
Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)
Date:5/4/2011

NEW YORK, May 4, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)

http://www.reportlinker.com/p0488653/European-Markets-for-Orthopedic-Biomaterials-2011-–-Bone-Grafting-and-Hyaluronic-Acid-Viscosupplementation-15-Countries.html

The European orthopedic biomaterials markets are expected to approach €1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment.

The European orthopedic biomaterials markets include:

- autologous bone grafts,

- bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),

- hyaluronic acid (HA) viscosupplementation,

- bone morphogenetic protein (BMP) growth factor therapy

- autologous chondrocyte implantation (ACI)

The European markets include:

- Germany,

- France,

- the United Kingdom,

- Spain,

- Italy,

- Benelux (Belgium, the Netherlands and Luxembourg),

- Scandinavia (Denmark, Finland, Norway and Sweden),

- Switzerland,

- Austria,

- Portugal and

- Greece

The ACI market grew most rapidly in 2010 at a rate of nearly 12%, followed by the BGS market. Within the European orthopedic biomaterials market, companies such as Fidia, Genzyme, Rottapharm/Madaus and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

TABLE OF CONTENTS

TABLE OF CONTENTS...I

LIST OF FIGURES.V

LIST OF CHARTS....XV

EXECUTIVE SUMMARY.... 1

1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS 1

1.2 AUTOGRAFTED BONE PROCEDURES.. 2

1.3 BONE GRAFT SUBSTITUTE MARKET.. 3

1.4 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET 4

1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 5

1.6 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET .... 6

1.7 COMPETITIVE ANALYSIS .... 7

RESEARCH METHODOLOGY.... 8

2.1 RESEARCH SCOPE 8

2.2 IDATA'S 9-STEP METHODOLOGY . 8

Step 1: Project Initiation & Team Selection 9

Step 2: Prepare Data Systems and Perform Secondary Research 10

Step 3: Preparation for Interviews & Questionnaire Design .. 11

Step 4: Performing Primary Research.. 12

Step 5: Research Analysis: Establishing Baseline Estimates .. 14

Step 6: Market Forecast and Analysis .. 14

Step 7: Identify Strategic Opportunities .... 16

Step 8: Final Review and Market Release . 17

Step 9: Customer Feedback and Market Monitoring 18

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS.... 19

3.1 INTRODUCTION .. 19

3.1.1 Products.. 20

3.1.1.1 Growth Factors..20

3.1.1.2 Bone Graft Substitutes .20

3.1.1.3 Hyaluronic Acid Viscosupplementation20

3.1.1.4 Autologous Chondrocyte Implantation.21

3.2 CURRENCY EXCHANGE RATE 21

3.3 MARKET OVERVIEW.... 22

3.4 MARKET BY SEGMENT. 24

3.5 TREND ANALYSIS BY SEGMENT . 29

3.6 MARKET BY COUNTRY 32

3.7 MARKET DRIVERS AND LIMITERS ... 35

3.7.1 Market Drivers.. 35

3.7.2 Market Limiters. 35

3.8 COMPETITIVE ANALYSIS .. 37

3.8.1 Market Concentration. 41

3.9 MERGERS AND ACQUISITIONS .... 42

COUNTRY PROFILES.. 43

4.1 INTRODUCTION .. 43

4.1.1 Population.... 43

4.1.2 GDP per Capita 43

4.1.3 Procedures ... 43

4.1.4 Price Index... 44

4.2 GERMANY 45

4.3 FRANCE.... 46

4.4 UNITED KINGDOM .. 47

4.5 SPAIN .. 48

4.6 ITALY .. 49

4.7 BENELUX . 50

4.8 SCANDINAVIA .... 51

4.9 SWITZERLAND.... 52

4.10 AUSTRIA 53

4.11 PORTUGAL .. 54

4.12 GREECE.. 55

BONE GRAFT SUBSTITUTE MARKET.. 56

5.1 INTRODUCTION .. 56

5.1.1 Volumes Represented per Procedure... 59

5.2 MARKET OVERVIEW.... 60

5.2.1 Total Bone Graft Substitute Procedures by Indication. 60

5.2.2 Total Bone Graft Substitute Procedures by Segment.... 63

5.2.3 Bone Graft Substitute Average Selling Price by Segment.. 67

5.2.4 Bone Graft Substitute Market by Segment 69

5.3 MARKET ANALYSIS AND FORECAST .... 74

5.3.1 Total Bone Graft Substitute Market 74

5.3.2 Total Allograft Market 82

5.3.2.1 Allograft Spine Market 91

5.3.2.2 Allograft Cervical Spine Market.99

5.3.2.3 Allograft Thoracolumbar Spine Market ..107

5.3.2.4 Allograft Trauma and Reconstruction Market...115

5.3.2.5 Allograft Craniomaxillofacial Market 123

5.3.3 Total Synthetic Material Market... 131

5.3.3.1 Synthetic Spine Market ...140

5.3.3.2 Synthetic Cervical Spine Market ...148

5.3.3.3 Synthetic Thoracolumbar Spine Market ..156

5.3.3.4 Synthetic Trauma and Reconstruction Market ..164

5.3.3.5 Synthetic Craniomaxillofacial Market172

5.3.4 Total DBM Market.... 180

5.3.4.1 DBM Spine Market ....188

5.3.4.2 DBM Cervical Spine Market ....196

5.3.4.3 DBM Thoracolumbar Spine Market ...204

5.3.4.4 DBM Trauma and Reconstruction Market ...212

5.3.4.5 DBM Craniomaxillofacial Market.220

5.4 MARKET DRIVERS AND LIMITERS . 228

5.4.1 Market Drivers 228

5.4.2 Market Limiters.... 229

5.5 COMPETITIVE ANALYSIS 232

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY

MARKET.. 238

6.1 INTRODUCTION 238

6.2 MARKET ANALYSIS AND FORECAST .. 240

6.3 MARKET DRIVERS AND LIMITERS . 247

6.3.1 Market Drivers 247

6.3.2 Market Limiters.... 247

6.4 COMPETITIVE ANALYSIS 249

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET .... 252

7.1 INTRODUCTION 252

7.2 MARKET OVERVIEW.. 254

7.3 MARKET ANALYSIS AND FORECAST .. 263

7.3.1 Total Hyaluronic Acid Viscosupplementation Market 263

7.3.2 Single-Injection Market . 269

7.3.3 Three-Injection Cycle Market .. 276

7.3.4 Five-Injection Cycle Market .... 283

7.4 MARKET DRIVERS AND LIMITERS . 290

7.4.1 Market Drivers 290

7.4.2 Market Limiters.... 290

7.5 COMPETITIVE ANALYSIS 293

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET... 298

8.1 INTRODUCTION 298

8.2 MARKET ANALYSIS AND FORECAST .. 300

8.3 MARKET DRIVERS AND LIMITERS . 307

8.3.1 Market Drivers 307

8.3.2 Market Limiters.... 307

8.4 COMPETITIVE ANALYSIS 309

ABBREVIATIONS... 314

APPENDIX: BONE CEMENT MARKET .... 315

10.1 BONE CEMENT MARKET ANALYSIS AND FORECAST. 315

LIST OF FIGURES

EXECUTIVE SUMMARY.... 1

RESEARCH METHODOLOGY. 8

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS .. 19

Figure 3-1: Exchange Rate between Selected European Currencies and the Euro,

2010 21

Figure 3-2: Total European Orthopedic Biomaterials Market, Europe,

2007 – 2017.... 22

Figure 3-3: Total Orthopedic Biomaterials Market, Europe, 2007 – 2017 (€M) .... 25

Figure 3-4: Total Orthopedic Biomaterials Market, Europe, 2007 – 2017 (US$M) 25

Figure 3-5: Orthopedic Biomaterials Market Growth Rates by Segment, Europe,

2007 – 2017.... 30

Figure 3-6: Orthopedic Biomaterials Market by Country, Europe, 2007 – 2017

(€M) 33

Figure 3-7: Orthopedic Biomaterials Market by Country, Europe, 2007 – 2017

(US$M) 34

Figure 3-8: Market Drivers and Limiters, Orthopedic Biomaterials Market,

Europe, 2010 .. 36

Figure 3-9: Leading Competitors, Orthopedic Biomaterials Market, Europe,

2010 39

Figure 3-10: Market Concentration, Orthopedic Biomaterials Market, Europe,

2010 41

COUNTRY PROFILES . 43

Figure 4-1: European Price Index for BGS Materials by Country, 2010 44

BONE GRAFT SUBSTITUTE MARKET 56

Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Europe, 2007

– 2017 .. 60

Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment,

Europe, 2007 – 2017 . 64

Figure 5-3: Bone Graft Substitute ASP by Segment, Europe, 2007 – 2017 (€) . 67

Figure 5-4: Bone Graft Substitute ASP by Segment, Europe, 2007 – 2017 (US$) . 68

Figure 5-5: Bone Graft Substitute Market by Segment, Europe, 2007 – 2017

(€M) 69

Figure 5-6: Bone Graft Substitute Market by Segment, Europe, 2007 – 2017

(US$M) 70

Figure 5-7: Total Bone Graft Substitute Procedures by Country, Europe,

2007 – 2017.... 75

Figure 5-8: Total Bone Graft Substitute Units Sold by Country, Europe,

2007 – 2017.... 76

Figure 5-9: Total Bone Graft Substitute ASP by Country, Europe, 2007 – 2017

(€) ... 77

Figure 5-10: Total Bone Graft Substitute ASP by Country, Europe, 2007 – 2017

(US$) ... 78

Figure 5-11: Total Bone Graft Substitute Market by Country, Europe, 2007 –

2017 (€M) . 79

Figure 5-12: Total Bone Graft Substitute Market by Country, Europe, 2007 –

2017 (US$M).. 80

Figure 5-13: Total Bone Graft Substitute Market, Europe, 2007 – 2017 (€M) . 81

Figure 5-14: Total Allograft Procedures by Country, Europe, 2007 – 2017 84

Figure 5-15: Total Allograft Units Sold by Country, Europe, 2007 – 2017 . 85

Figure 5-16: Total Allograft ASP by Country, Europe, 2007 – 2017 (€) 86

Figure 5-17: Total Allograft ASP by Country, Europe, 2007 – 2017 (US$) 87

Figure 5-18: Total Allograft Market by Country, Europe, 2007 – 2017 (€M)... 88

Figure 5-19: Total Allograft Market by Country, Europe, 2007-2017 (US$M) 89

Figure 5-20: Allograft Total Spine Procedures by Country, Europe, 2007 – 2017. 92

Figure 5-21: Allograft Total Spine Units Sold by Country, Europe, 2007 – 2017 . 93

Figure 5-22: Allograft Total Spine ASP by Country, Europe, 2007 – 2017 (€) 94

Figure 5-23: Allograft Total Spine ASP by Country, Europe, 2007 – 2017 (US$). 95

Figure 5-24: Allograft Total Spine Market by Country, Europe, 2007 – 2017

(€M) 96

Figure 5-25: Allograft Total Spine Market by Country, Europe, 2007 – 2017

(US$M) 97

Figure 5-26: Allograft Cervical Spine Procedures by Country, Europe,

2007 – 2017.. 100

Figure 5-27: Allograft Cervical Spine Units Sold by Country, Europe,

2007 – 2017.. 101

Figure 5-28: Allograft Cervical Spine ASP by Country, Europe, 2007 – 2017

(€) . 102

Figure 5-29: Allograft Cervical Spine ASP by Country, Europe, 2007 – 2017

(US$) . 103

Figure 5-30: Allograft Cervical Spine Market by Country, Europe, 2007 – 2017

(€M)... 104

Figure 5-31: Allograft Cervical Spine Market by Country, Europe, 2007 – 2017

(US$M) ... 105

Figure 5-32: Allograft Thoracolumbar Spine Procedures by Country, Europe,

2007 – 2017.. 108

Figure 5-33: Allograft Thoracolumbar Spine Units Sold by Country, Europe,

2007 – 2017.. 109

Figure 5-34: Allograft Thoracolumbar Spine ASP by Country, Europe,

2007 – 2017 (€) . 110

Figure 5-35: Allograft Thoracolumbar Spine ASP by Country, Europe,

2007 – 2017 (US$).. 111

Figure 5-36: Allograft Thoracolumbar Spine Market by Country, Europe,

2007 – 2017 (€M) ... 112

Figure 5-37: Allograft Thoracolumbar Spine Market by Country, Europe,

2007 – 2017 (US$M) ... 113

Figure 5-38: Allograft Trauma and Reconstruction Procedures by Country,

Europe, 2007 – 2017 .... 116

Figure 5-39: Allograft Trauma and Reconstruction Units Sold by Country,

Europe, 2007 – 2017 .... 117

Figure 5-40: Allograft Trauma and Reconstruction ASP by Country, Europe,

2007 – 2017 (€) . 118

Figure 5-41: Allograft Trauma and Reconstruction ASP by Country, Europe,

2007 – 2017 (US$).. 119

Figure 5-42: Allograft Trauma and Reconstruction Market by Country, Europe,

2007 – 2017 (€M) ... 120

Figure 5-43: Allograft Trauma and Reconstruction Market by Country, Europe,

2007 – 2017 (US$M) ... 121

Figure 5-44: Allograft Craniomaxillofacial Procedures by Country, Europe,

2007 – 2017.. 124

Figure 5-45: Allograft Craniomaxillofacial Units Sold by Country, Europe,

2007 – 2017.. 125

Figure 5-46: Allograft Craniomaxillofacial ASP by Country, Europe, 2007 – 2017

(€) . 126

Figure 5-47: Allograft Craniomaxillofacial ASP by Country, Europe, 2007 – 2017

(US$) . 127

Figure 5-48: Allograft Craniomaxillofacial Market by Country, Europe,

2007 – 2017 (€M) ... 128

Figure 5-49: Allograft Craniomaxillofacial Market by Country, Europe,

2007 – 2017 (US$M) ... 129

Figure 5-50: Total Synthetic Procedures by Country, Europe, 2007 – 2017 ... 133

Figure 5-51: Total Synthetic Units Sold by Country, Europe, 2007 – 2017.... 134

Figure 5-52: Total Synthetic ASP by Country, Europe, 2007 – 2017 (€) .. 135

Figure 5-53: Total Synthetic ASP by Country, Europe, 2007 – 2017 (US$)... 136

Figure 5-54: Total Synthetic Market by Country, Europe, 2007 – 2017 (€M) 137

Figure 5-55: Total Synthetic Market by Country, Europe, 2007 – 2017 (US$M) 138

Figure 5-56: Synthetic Spine Procedures by Country, Europe, 2007 – 2017 .. 141

Figure 5-57: Synthetic Spine Units Sold by Country, Europe, 2007 – 2017 ... 142

Figure 5-58: Synthetic Spine ASP by Country, Europe, 2007 – 2017 (€) .. 143

Figure 5-59: Synthetic Spine ASP by Country, Europe, 2007 – 2017 (US$) .. 144

Figure 5-60: Synthetic Spine Market by Country, Europe, 2007 – 2017 (€M) 145

Figure 5-61: Synthetic Spine Market by Country, Europe, 2007 – 2017 (US$M) 146

Figure 5-62: Synthetic Cervical Spine Procedures by Country, Europe,

2007 – 2017.. 149

Figure 5-63: Synthetic Cervical Spine Units Sold by Country, Europe,

2007 – 2017.. 150

Figure 5-64: Synthetic Cervical Spine ASP by Country, Europe, 2007 – 2017

(€) . 151

Figure 5-65: Synthetic Cervical Spine ASP by Country, Europe, 2007 – 2017

(US$) . 152

Figure 5-66: Synthetic Cervical Spine Market by Country, Europe, 2007 – 2017

(€M)... 153

Figure 5-67: Synthetic Cervical Spine Market by Country, Europe, 2007 – 2017

(US$M) ... 154

Figure 5-68: Synthetic Thoracolumbar Spine Procedures by Country, Europe,

2007 – 2017.. 157

Figure 5-69: Synthetic Thoracolumbar Spine Units Sold by Country, Europe,

2007 – 2017.. 158

Figure 5-70: Synthetic Thoracolumbar Spine ASP by Country, Europe,

2007 – 2017 (€) . 159

Figure 5-71: Synthetic Thoracolumbar Spine ASP by Country, Europe,

2007 – 2017 (US$).. 160

Figure 5-72: Synthetic Thoracolumbar Spine Market by Country, Europe,

2007 – 2017 (€M) ... 161

Figure 5-73: Synthetic Thoracolumbar Spine Market by Country, Europe,

2007 – 2017 (US$M) ... 162

Figure 5-74: Synthetic Trauma and Reconstruction Procedures by Country,

Europe, 2007 – 2017 .... 165

Figure 5-75: Synthetic Trauma and Reconstruction Units Sold by Country,

Europe, 2007 – 2017 .... 166

Figure 5-76: Synthetic Trauma and Reconstruction ASP by Country, Europe,

2007 – 2017 (€) . 167

Figure 5-77: Synthetic Trauma and Reconstruction ASP by Country, Europe,

2007 – 2017 (US$).. 168

Figure 5-78: Synthetic Trauma and Reconstruction Market by Country, Europe,

2007 – 2017 (€M) ... 169

Figure 5-79: Synthetic Trauma and Reconstruction Market by Country, Europe,

2007 – 2017 (US$M) ... 170

Figure 5-80: Synthetic Craniomaxillofacial Procedures by Country, Europe,

2007 – 2017.. 173

Figure 5-81: Synthetic Craniomaxillofacial Units Sold by Country, Europe,

2007 – 2017.. 174

Figure 5-82: Synthetic Craniomaxillofacial ASP by Country, Europe,

2007 – 2017 (€) . 175

Figure 5-83: Synthetic Craniomaxillofacial ASP by Country, Europe,

2007 – 2017 (US$).. 176

Figure 5-84: Synthetic Craniomaxillofacial Market by Country, Europe,

2007 – 2017 (€M) ... 177

Figure 5-85: Synthetic Craniomaxillofacial Market by Country, Europe,

2007 – 2017 (US$M) ... 178

Figure 5-86: Total DBM Procedures by Country, Europe, 2007 – 2017 .... 181

Figure 5-87: Total DBM Units Sold by Country, Europe, 2007 – 2017 182

Figure 5-88: Total DBM ASP by Country, Europe, 2007 – 2017 (€) ... 183

Figure 5-89: Total DBM ASP by Country, Europe, 2007 – 2017 (US$).... 184

Figure 5-90: Total DBM Market by Country, Europe, 2007 – 2017 (€M) . 185

Figure 5-91: Total DBM Market by Country, Europe, 2007 – 2017 (US$M) . 186

Figure 5-92: DBM Spine Procedures by Country, Europe, 2007 – 2017 ... 189

Figure 5-93: DBM Spine Units Sold by Country, Europe, 2007 – 2017 .... 190

Figure 5-94: DBM Spine ASP by Country, Europe, 2007 – 2017 (€) ... 191

Figure 5-95: DBM Spine ASP by Country, Europe, 2007 – 2017 (US$) ... 192

Figure 5-96: DBM Spine Market by Country, Europe, 2007 – 2017 (€M). 193

Figure 5-97: DBM Spine Market by Country, Europe, 2007 – 2017 (US$M) . 194

Figure 5-98: DBM Cervical Spine Procedures by Country, Europe,

2007 – 2017.. 197

Figure 5-99: DBM Cervical Spine Units Sold by Country, Europe, 2007 – 2017 198

Figure 5-100: DBM Cervical Spine ASP by Country, Europe, 2007 – 2017 (€) .. 199

Figure 5-101: DBM Cervical Spine ASP by Country, Europe, 2007 – 2017

(US$) . 200

Figure 5-102: DBM Cervical Spine Market by Country, Europe, 2007 – 2017

(€M)... 201

Figure 5-103: DBM Cervical Spine Market by Country, Europe, 2007 – 2017

(US$M) ... 202

Figure 5-104: DBM Thoracolumbar Spine Procedures by Country, Europe,

2007 – 2017.. 205

Figure 5-105: DBM Thoracolumbar Spine Units Sold by Country, Europe,

2007 – 2017.. 206

Figure 5-106: DBM Thoracolumbar Spine ASP by Country, Europe, 2007 – 2017

(€) . 207

Figure 5-107: DBM Thoracolumbar Spine ASP by Country, Europe, 2007 – 2017

(US$) . 208

Figure 5-108: DBM Thoracolumbar Spine Market by Country, Europe,

2007 – 2017 (€M) ... 209

Figure 5-109: DBM Thoracolumbar Spine Market by Country, Europe,

2007 – 2017 (US$M) ... 210

Figure 5-110: DBM Trauma and Reconstruction Procedures by Country, Europe,

2007 – 2017.. 213

Figure 5-111: DBM Trauma and Reconstruction Units Sold by Country, Europe,

2007 – 2017.. 214

Figure 5-112: DBM Trauma and Reconstruction ASP by Country, Europe,

2007 – 2017 (€) . 215

Figure 5-113: DBM Trauma and Reconstruction ASP by Country, Europe,

2007 – 2017 (US$).. 216

Figure 5-114: DBM Trauma and Reconstruction Market by Country, Europe,

2007 – 2017 (€M) ... 217

Figure 5-115: DBM Trauma and Reconstruction Market by Country, Europe,

2007 – 2017 (US$M) ... 218

Figure 5-116: DBM Craniomaxillofacial Procedures by Country, Europe,

2007 – 2017.. 221

Figure 5-117: DBM Craniomaxillofacial Units Sold by Country, Europe,

2007 – 2017.. 222

Figure 5-118: DBM Craniomaxillofacial ASP by Country, Europe, 2007 – 2017

(€) . 223

Figure 5-119: DBM Craniomaxillofacial ASP by Country, Europe, 2007 – 2017

(US$) . 224

Figure 5-120: DBM Craniomaxillofacial Market by Country, Europe,

2007 – 2017 (€M) ... 225

Figure 5-121: DBM Craniomaxillofacial Market by Country, Europe,

2007 – 2017 (US$M) ... 226

Figure 5-122: Drivers and Limiters, Bone Graft Substitute Market, Europe, 2007

– 2017 231

Figure 5-123: Leading Competitors, Bone Graft Substitute Market by Country,

Europe, 2010 236

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY

MARKET 238

Figure 6-1: Bone Morphogenetic Protein Growth Factor Units (Vials), Europe,

2007 – 2017.. 241

Figure 6-2: Bone Morphogenetic Protein Growth Factor ASP, Europe,

2007 – 2017 (€) . 242

Figure 6-3: Bone Morphogenetic Protein Growth Factor ASP, Europe,

2007 – 2017 (US$).. 243

Figure 6-4: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe,

2007 – 2017 (€M) ... 244

Figure 6-5: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe,

2007 – 2017 (US$M) ... 245

Figure 6-6: Drivers and Limiters, Bone Morphogenetic Growth Factor Therapy

Market, Europe, 2007 – 2017 . 248

Figure 6-7: Leading Competitors, Bone Morphogenetic Growth Factor Therapy

Market, Europe, 2010 .. 250

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET... 252

Figure 7-1: Total Hyaluronic Acid Viscosupplementation Procedures by Segment,

Europe, 2007 – 2017 .... 255

Figure 7-2: Total Hyaluronic Acid Viscosupplementation ASP by Segment,

Europe, 2007 – 2017 (€) ... 256

Figure 7-3: Total Hyaluronic Acid Viscosupplementation ASP by Segment,

Europe, 2007 – 2017 (US$).... 257

Figure 7-4: Total Hyaluronic Acid Viscosupplementation Market by Segment,

Europe, 2007 – 2017 (€M) 258

Figure 7-5: Total Hyaluronic Acid Viscosupplementation Market by Segment,

Europe, 2007 – 2017 (US$M). 259

Figure 7-6: Total Hyaluronic Acid Viscosupplement Injections by Country,

Europe, 2007 – 2017 .... 264

Figure 7-7: Hyaluronic Acid Viscosupplementation ASP by Country, Europe,

2007 – 2017 (€) . 265

Figure 7-8: Hyaluronic Acid Viscosupplementation ASP by Country, Europe,

2007 – 2017 (US$).. 266

Figure 7-9: Total Hyaluronic Acid Viscosupplementation Market by Country,

Europe, 2007 – 2017 (€M) 267

Figure 7-10: Total Hyaluronic Acid Viscosupplementation Market by Country,

Europe, 2007 – 2017 (US$M). 268

Figure 7-11: Single-Injection Procedures by Country, Europe, 2007 – 2017.. 270

Figure 7-12: Single-Injection ASP by Country, Europe, 2007 – 2017 (€) . 271

Figure 7-13: Single-Injection ASP by Country, Europe, 2007 – 2017 (US$).. 272

Figure 7-14: Single-Injection Market by Country, Europe, 2007 – 2017 (€M) .... 273

Figure 7-15: Single-Injection Market by Country, Europe, 2007 – 2017

(US$M) ... 274

Figure 7-16: Three-Injection Cycle Procedures by Country, Europe,

2007 – 2017.. 277

Figure 7-17: Three-Injection Cycle ASP by Country, Europe, 2007 – 2017 (€) .. 278

Figure 7-18: Three-Injection Cycle ASP by Country, Europe, 2007 – 2017

(US$) . 279

Figure 7-19: Three-Injection Cycle Market by Country, Europe, 2007 – 2017

(€M)... 280

Figure 7-20: Three-Injection Cycle Market by Country, Europe, 2007 – 2017

(US$M) ... 281

Figure 7-21: Five-Injection Cycle Procedures by Country, Europe,

2007 – 2017.. 284

Figure 7-22: Five-Injection Cycle ASP by Country, Europe, 2007 – 2017 (€) .... 285

Figure 7-23: Five-Injection Cycle ASP by Country, Europe, 2007 – 2017 (US$) 286

Figure 7-24: Five-Injection Cycle Market by Country, Europe, 2007 – 2017

(€M)... 287

Figure 7-25: Five-Injection Cycle Market by Country, Europe, 2007 – 2017

(US$M) ... 288

Figure 7-26: Drivers and Limiters, Hyaluronic Acid Viscosupplementation

Market, Europe, 2007 – 2017 . 292

Figure 7-27: Leading Competitors, Hyaluronic Acid Viscosupplementation

Market, Europe, 2010 .. 296

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET.. 298

Figure 8-1: Autologous Chondrocyte Implantation Market, Europe, 2007 – 2017

(€) . 302

Figure 8-2: Autologous Chondrocyte Implantation Market, Europe, 2007 – 2017

(US$) . 302

Figure 8-3: Autologous Chondrocyte Implantation Units Sold by Country,

Europe, 2007 – 2017 .... 303

Figure 8-4: Autologous Chondrocyte Implantation Market by Country, Europe,

2007 – 2017 (€M) ... 304

Figure 8-5: Autologous Chondrocyte Implantation Market by Country, Europe,

2007 – 2017 (US$M) ... 305

Figure 8-6: Drivers and Limiters, Autologous Chondrocyte Implantation Market,

Europe, 2010 308

Figure 8-7: Leading Competitors, Autologous Chondrocyte Implantation Market,

Europe, 2010 312

ABBREVIATIONS 314

APPENDIX: BONE CEMENT MARKET... 315

Figure 10-1: Premixed Antibiotic Bone Cement Market, Europe, 2007 – 2017

(€) . 316

Figure 10-2: Premixed Antibiotic Bone Cement Market, Europe, 2007 – 2017

(US$) . 316

Figure 10-3: Traditional Bone Cement Market, Europe, 2007-2017 (€) .... 317

Figure 10-4: Traditional Bone Cement Market, Europe, 2007 – 2017 (US$).. 317

Figure 10-5: Leading Competitors, Bone Cement Market, Europe, 2010 .. 318

LIST OF CHARTS

EXECUTIVE SUMMARY.... 1

Chart 1-1: Total Orthopedic Biomaterials Markets, Europe, 2007 – 2017 (€M) . 1

Chart 1-2: Autograft Procedures, Europe, 2017 ... 2

Chart 1-3: Orthopedic Procedures by Bone Graft Substitute, Europe, 2010 .. 3

Chart 1-4: BMP Growth Factor Market, Europe, 2007 – 2017 (€M) ... 4

Chart 1-5: Hyaluronic Acid Viscosupplementation Market by Segment, Europe,

2007 – 2017. 5

Chart 1-6: Autologous Chondrocyte Implantation Market, Europe, 2007 – 2017

(€M).. 6

Chart 1-7: Leading Competitors, Orthopedic Biomaterial Markets, Europe, 2010... 7

RESEARCH METHODOLOGY. 8

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS .. 19

Chart 3-1: Total European Orthopedic Biomaterials Market, Europe, 2007 – 2017

(€M) 23

Chart 3-2: Total Orthopedic Biomaterials Market by Segment, Europe,

2007 – 2017 (€M) 26

Chart 3-3: Total Orthopedic Biomaterials Market by Segment, Europe, 2010.. 27

Chart 3-4: Total Orthopedic Biomaterials Market by Segment, Europe, 2017.. 28

Chart 3-5: Total European Orthopedic Biomaterials Market by Segment, Europe,

2008 – 2017.... 31

Chart 3-6: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2010. 40

COUNTRY PROFILES . 43

Chart 4-1: Country Profile, Germany, 2010.. 45

Chart 4-2: Country Profile, France, 2010 46

Chart 4-3: Country Profile, U.K., 2010 ... 47

Chart 4-4: Country Profile, Spain, 2010 .. 48

Chart 4-5: Country Profile, Italy, 2010 ... 49

Chart 4-6: Country Profile, Benelux, 2010 ... 50

Chart 4-7: Country Profile, Scandinavia, 2010 .. 51

Chart 4-8: Country Profile, Switzerland, 2010 .. 52

Chart 4-9: Country Profile, Austria, 2010 .... 53

Chart 4-10: Country Profile, Portugal, 2010 . 54

Chart 4-11: Country Profile, Greece, 2010 ... 55

BONE GRAFT SUBSTITUTE MARKET 56

Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication, Europe,

2010 61

Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication, Europe,

2017 62

Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment,

Europe, 2010 .. 65

Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment,

Europe, 2017 .. 66

Chart 5-5: Bone Graft Substitute Market by Segment, Europe, 2007 – 2017 (€M) 71

Chart 5-6: Bone Graft Substitute Market by Segment, Europe, 2010 72

Chart 5-7: Bone Graft Substitute Market by Segment, Europe, 2017 73

Chart 5-8: Total Allograft Market, Europe, 2007 – 2017 (€M).... 90

Chart 5-9: Allograft Total Spine Market, Europe, 2007 – 2017 (€M) .... 98

Chart 5-10: Allograft Cervical Spine Market, Europe, 2007 – 2017 (€M). 106

Chart 5-11: Allograft Thoracolumbar Spine Market, Europe, 2007 – 2017 (€M) 114

Chart 5-12: Allograft Trauma and Reconstruction Market, Europe, 2007 – 2017

(€M)... 122

Chart 5-13: Allograft Craniomaxillofacial Market, Europe, 2007 – 2017 (€M)... 130

Chart 5-14: Total Synthetic Market, Europe, 2007 – 2017 (€M) 139

Chart 5-15: Synthetic Spine Market, Europe, 2007 – 2017 (€M) .... 147

Chart 5-16: Synthetic Cervical Spine Market, Europe, 2007 – 2017 (€M) 155

Chart 5-17: Synthetic Thoracolumbar Spine Market, Europe, 2007 – 2017 (€M) 163

Chart 5-18: Synthetic Trauma and Reconstruction Spine Market, Europe,

2007 – 2017 (€M) ... 171

Chart 5-19: Synthetic Craniomaxillofacial Spine Market, Europe, 2007 – 2017

(€M)... 179

Chart 5-20: Total DBM Market, Europe, 2007 – 2017 (€M). 187

Chart 5-21: DBM Spine Market, Europe, 2007 – 2017 (€M) 195

Chart 5-22: DBM Cervical Spine Market, Europe, 2007 – 2017 (€M) . 203

Chart 5-23: DBM Thoracolumbar Spine Market, Europe, 2007 – 2017 (€M) . 211

Chart 5-24: DBM Trauma and Reconstruction Spine Market, Europe,

2007 – 2017 (€M) ... 219

Chart 5-25: DBM Craniomaxillofacial Spine Market, Europe, 2007 – 2017

(€M)... 227

Chart 5-26: Leading Competitors, Bone Graft Substitute Market by Country,

Europe, 2010 237

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY

MARKET 238

Chart 6-1: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe,

2007 – 2017 (€M) ... 246

Chart 6-2: Leading Competitors, Bone Morphogenetic Growth Factor Therapy

Market, Europe, 2010 .. 251

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET... 252

Chart 7-1: Total Hyaluronic Acid Viscosupplementation Market, Europe,

2007 – 2017 (€M) ... 260

Chart 7-2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe,

2010 ... 261

Chart 7-3: Hyaluronic Acid Viscosupplementation Market by Segment, Europe,

2017 ... 262

Chart 7-4: Total Single-Injection Hyaluronic Acid Viscosupplementation Market,

Europe, 2007 – 2017 (€M) .... 275

Chart 7-5: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market,

Europe, 2007 – 2017 (€M) 282

Chart 7-6: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market,

Europe, 2007 – 2017 (€M) 289

Chart 7-7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market,

Europe, 2010 297

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET.. 298

Chart 8-1: Autologous Chondrocyte Implantation Market, Europe, 2007 – 2017

(€M)... 306

Chart 8-2: Leading Competitors, Autologous Chondrocyte Implantation Market,

Europe, 2010 313

ABBREVIATIONS 314

APPENDIX: BONE CEMENT MARKET... 315

Chart 10-1: Leading Competitors, Bone Cement Market, Europe, 2010.... 319

To order this report:

: European Markets for Orthopedic Biomaterials 2011 – Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... 11, 2016 Laboratory glassware and ... laboratories. These may range from microscope slides to large ... made from borosilicate glass because of its low weight ... other hand, started gaining popularity over the past decade ... replace glass with plastic in several applications due to ...
(Date:2/11/2016)... 2016  Governor Andrew M. Cuomo today announced a ... throughout Western New York . This ... Polytechnic Institute, includes a major expansion of Athenex,s North ... Buffalo , as well as the creation of ... Dunkirk . The combined projects are expected ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... ... “ HEALING MIND : Five Steps to Ultimate Healing, Four Rooms ... teaches readers how to become their own therapist. Providing a useful step-by-step process for ... offers an understanding of how to heal one’s inner child using four archetypes of ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... (DMPG) will use the action analytics leader’s population health solutions, MDinsight® and ... clinical support to the Atlanta-area healthcare system. Details of the contract were not ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Registered nurses, ... free CEU seminar titled, “Stroke Management: Time to Act, Time to Heal” on Thursday, ... in Whippany, N.J. The presenter is Vishal Chedda, president of ANSA Consultants, who ...
(Date:2/11/2016)... FL (PRWEB) , ... February 11, 2016 , ... Florida ... Bay Lightning take on the St. Louis Blues at the Amalie Arena. The puck ... portable, inflatable, walk-through heart exhibit, the MEGA Heart, prior to the game. The MEGA ...
(Date:2/11/2016)... ... February 11, 2016 , ... Image One USA veteran franchise owner ... it’s the buildings of Nashville that will benefit. , “I’ve enjoyed being a part ... Nashville, there was no question that I would bring my business with me,” Bogacki ...
Breaking Medicine News(10 mins):